López-Marte P, Rosado-Carrión B. Grade 3 Severe Liver Injury Secondary to Pembrolizumab. PRHSJ [Internet]. 2023 Sep. 7 [cited 2025 Oct. 26];42(3):254-5. Available from: https://prhsj.rcm.upr.edu/index.php/prhsj/article/view/2954